Observations placeholder

World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121.  Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.  Tomasello G1, Tralongo P1, Damiani P1, Sinagra E1, Di Trapani B1, Zeenny MN1, Hussein IH1, Jurjus A1, Leone A1.  1Giovanni Tomasello, Emanuele Sinagra, Benedetto Di Trapani, IEMEST, Euro-Mediterranean Institute of Science and Technology, 90139 Palermo, Italy.

Patients with inflammatory bowel disease (IBD) have an increased risk of 10%-15% developing colorectal cancer (CRC) that is a common disease of high economic costs in developed countries.

The CRC has been increasing in recent years and its mortality rates are very high. Multiple biological and biochemical factors are responsible for the onset and progression of this pathology. Moreover, it appears absolutely necessary to investigate the environmental factors favoring the onset of CRC and the promotion of colonic health.

The gut microflora, or microbiota, has an extensive diversity both quantitatively and qualitatively. In utero, the intestine of the mammalian fetus is sterile. At birth, the intestinal microbiota is acquired by ingesting maternal anal or vaginal organisms, ultimately developing into a stable community, with marked variations in microbial composition between individuals.

The development of IBD is often associated with qualitative and quantitative disorders of the intestinal microbial flora (dysbiosis).

The healthy human gut harbours about 10 different bacterial species distributed in colony forming units which colonize the gastrointestinal tract. The intestinal microbiota plays a fundamental role in health and in the progression of diseases such as IBD and CRC. In healthy subjects, the main control of intestinal bacterial colonization occurs through gastric acidity but other factors such as endoluminal temperature, competition between different bacterial strains, peristalsis and drugs can influence the intestinal microenvironment.

The microbiota exerts diverse physiological functions to include: growth inhibition of pathogenic microorganisms, synthesis of compounds useful for the trophism of colonic mucosa, regulation of intestinal lymphoid tissue and synthesis of amino acids. Furthermore, mucus seems to play an important role in protecting the intestinal mucosa and maintaining its integrity. Changes in the microbiota composition are mainly influenced by diet and age, as well as genetic factors.

Increasing evidence indicates that dysbiosis favors the production of genotoxins and metabolites associated with carcinogenesis and induces dysregulation of the immune response which promotes and sustains inflammation in IBD leading to carcinogenesis. A disequilibrium in gut microflora composition leads to the specific activation of gut associated lymphoid tissue.

The associated chronic inflammatory process associated increases the risk of developing CRC.

Ulcerative colitis and Crohn's disease are the two major IBDs characterized by an early onset and extraintestinal manifestations, such as rheumatoid arthritis. The pathogenesis of both diseases is complex and not yet fully known. However, it is widely accepted that  immune response can play a pivotal role in IBD pathogenesis.

KEYWORDS:

Colorectal Cancer; Dismicrobism; Dysbiosis; Eubiosis; Heat shock proteins; Inflammatory bowel disease

PMID:

25561781